Navigation Links
AMRESCO Invests in New Powder Manufacturing Facility to Support Growth in Life Science Business
Date:6/25/2013

Cleveland, Ohio (PRWEB) June 25, 2013

AMRESCO, LLC, a VWR company and a Life Science leader in the supply and contract manufacturing of high purity biochemicals, reagents and research products, announced that it has invested in a new powder manufacturing facility to support growing global business to Diagnostic, Molecular Biology and Biopharmaceutical companies. AMRESCO’s investment is part of its ongoing strategy to help increase its customers’ operational efficiencies and profitability. Its breadth of services and manufacturing capabilities offers a strong value platform and strengthens its mission to support customers and their products.

AMRESCO’s new facility increases its powder manufacturing capacity by 150%, expanding capabilities for particle size reduction, homogenous powder blending, precision powder dosing for pouching, and tablet production. This expanded and enhanced production helps to support growing product lines such as buffer blends and dehydrated media blends.

Over 35% of AMRESCO’s customers require specific formulation needs. The additional powder manufacturing capabilities and capacity allow AMRESCO to manufacture, dose and package a wider variety of powder products with varying volumes, as well as offer customers the sensitivity and most importantly, the throughput that their product requires.

Jim Taliak, VP of Global Sales at AMRESCO states, “Our customers are challenged with speed to market, operational constraints, and lack of capital or expertise. They are focusing on activities and efforts that don’t always align with their best strategic interest. Together, we look at where they need to be, then employ our skill and capabilities to assure their success.”

ABOUT AMRESCO
For nearly four decades, AMRESCO has been serving life sciences research and commercial production customers worldwide, bringing them high purity biochemicals, custom manufacturing solutions, inno
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. AMRESCO’s New Fluorescent DNA Quantitation Kit Uses a Highly Specific DNA-binding Dye that Allows Accurate Quantitation Even in Crude Extracts
2. AMRESCO’s New VisiGlo™ Prime and VisiGlo™ Select HRP Chemiluminescent Substrate Kits Offer Long-lasting, High Sensitivity Detection
3. AMRESCO Offers New Prism Protein Marker With Vibrant Colors For Easy Band Identification
4. DuPont, American Farm Bureau Foundation Invests $250,000 in My American Farm Web Education Program
5. UPMC Invests in Intelligent Infrastructure with IBM to Support Vision of Personalized Medicine
6. JumpStart Invests $250,000 in Milo Biotechnology
7. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
8. SAFC Expands Irvine Facility to Add Dry Powder Media Manufacturing Capabilities
9. TM&S Opens Office Dedicated to Powder Metal, Metal Injection Molding and Liquid Metal
10. Rigaku Publishes New Application for Cement Analysis by the Pressed Powder Method on the ZSX Primus III+ According to ASTM C114-11
11. Rigaku Publishes New Application Note: Cement Raw Meal Analysis by Pressed Powder Method on the ZSX Primus III+
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015 Working in collaboration ... in London , Richmond Pharmacology is the ... Phase 3 study for an investigational RNAi therapeutic being developed ... affecting the nerves and heart. Read press ... Based at St Georges University of ...
(Date:3/27/2015)... ROCKVILLE, Md. , March 27, 2015  CASI ... dedicated to the acquisition, development and commercialization of innovative ... the global market with a commercial focus on ... the three and 12 months ended December 31, 2014.  ... of ($1.6 million), or ($0.05) per share, for the ...
(Date:3/26/2015)... 2015  Roka Bioscience, Inc. (NASDAQ: ROKA ... advanced testing solutions for the detection of foodborne ... three months and full year ended December 31, ... for the quarter ended December 31, 2014 was ... quarter of 2013 and $1.5 million for the ...
(Date:3/26/2015)... TORONTO , March 26, 2015 /PRNewswire/ - SQI ... SQIDF) announced that after dealing with certain matters, including ... of shareholders held on March 26, 2015 (the "Meeting") ... until April 8, 2015 at 11:00 a.m. ( ... Meeting has been changed from that previous disclosed. The ...
Breaking Biology Technology:CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 2Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 5Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 7SQI Diagnostics Inc. Announces Adjournment of Meeting 2
... Netherlands , April 28, 2010 , Pepscan, the Netherlands ... of immune therapeutics, today,announced that it reached a partnering agreement for ... of the,agreement Pepscan will receive an undisclosed cash payment as well ... , , ...
... , S-HERTOGENBOSCH, The Netherlands , April ... novel methods in,immunotherapy with the most recent insights in oncology to develop ... , , ... Netherlands , April 27, 2010 - Immunovo BV, a new,biotechnology ...
... The Johns Hopkins University School of Medicine and The ... to advance the development and use of stem cells in therapies for a ... to use stem cells and foster joint research projects. , ... The collaborative program will encompass training for Johns ...
Cached Biology Technology:Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio 2Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio 3Immunovo BV- A New Biotechnology Company is Announced 2The New York Stem Cell Foundation and The Johns Hopkins University School of Medicine to Collaborate on Stem Cell Research 2The New York Stem Cell Foundation and The Johns Hopkins University School of Medicine to Collaborate on Stem Cell Research 3The New York Stem Cell Foundation and The Johns Hopkins University School of Medicine to Collaborate on Stem Cell Research 4The New York Stem Cell Foundation and The Johns Hopkins University School of Medicine to Collaborate on Stem Cell Research 5
(Date:3/3/2015)... March 3, 2015 Cryoport, Inc. ... advanced cryogenic logistics solutions for the life ... cells, cell lines, clinical research organizations, vaccine ... announced the expansion of its relationship with ... ("Fred Hutch") Clinical Research Division with the ...
(Date:3/2/2015)... HUNTSVILLE, Ala. , March 2, 2015 /PRNewswire/ ... transaction processing. Data protection company Tharon Rankins Enterprises ... product that provides an ultra-safe way for businesses ... as their financial transactions. Beconux ... by Tharon Rankins Enterprises. Functioning similarly to an ...
(Date:2/25/2015)... Feb. 25, 2015  ABC Financial Services (ABC), ... the Health and Fitness Industry, today announced enhancements ... MYiCLUBonline.  The latest upgrade includes advances to the ... cardless check-in via Identity One fingerprint biometrics. The ... through interactive displays at the International Health, Racquet ...
Breaking Biology News(10 mins):Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3Personal Data Protection Company Launches New Product 2ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3
... jobs, clean energy and a more sustainable use of ... talks. During the summit, the role of Earth observation ... blueprint to rethink economic growth, advance social equity and ... in Rio de Janeiro, Brazil. ,Now, 20 years later, ...
... previously documented that substances from the South African plant ... daffodils have an effect on the mechanisms in ... has now yielded further results, since a team based ... recently shown how several South African daffodils contain plant ...
... Innes Centre is the author of a new book ... define life. http://youtu.be/urDhZkCtkvM What ... develops into an infant, a child who learns to ... For many years, scientists have generally thought these great ...
Cached Biology News:Earth observation for us and our planet 2South African daffodils may be a future cure for depression 2'Cells to Civilizations: The Principles of Change That Shape Life' 2
... PP2A1, purified Formulation: 50mM Tris-HCl, ... Brij-35, 0.2mM PMSF, 1mM benzamidine, ... Properites: PP2A1 (Protein Phosphatase 2A1) ... ammonium sulfate precipitation, QSepharose,amino-hexyl agarose, ...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
...
... Immunogen : Recombinant human HMGN2/HMG-17 ... BSA, 0.15M NaCl, 0.05% sodium ... glycerol to 30% Quality Assurance: ... acid extracts of murine 10T ...
Biology Products: